Changing Innovation in the Pharmaceutical Industry

- A. Jungmittag, G. Reger, T. Reiss: Introduction.
- New Ways in Drug Development: Changes of the Locus of Innovation.
- Research Approach.
- A. Jungmittag: The National System of Innovation in the United States in Germany.
- The Concept of the "Systems of Innovation" Approach.
- Systems of Innovation in the German and US Pharmaceutical Sector.
- A. Jungmittag, G. Reger: Dynamics of the Markets and Market Structure.
- Introduction: Market Categories and Structure.
- Production, Consumption and Employment.
- Foreign Trade and Foreign Direct Investment.
- Conclusions for the International Competitiveness of Selected Countries.
- T. Reiss, S. Hinze: Innovation Process and Techno-scientific Dynamics.
- Innovation Process in Pharmaceuticals.
- Techno-Scientific Changes.
- A. Hullmann: Generation, Transfer and Exploitation of New Knowledge.
- Changes in the Division of Labor.
- Alliances of Pharmaceutical Firms.
- Results of the Empirical Analyses.
- Conclusions.
- G. Reger: Internationalization of Research and Development in Pharmaceuticals.
- Introduction.
- R&D and Technological Specialization on Country Level.
- Internationalization Strategies of Selected Pharmaceutical Companies.
- Conclusions.
- S. Hinze, T. Reiss: Case Study on New Therapies for Selected Autoimmune Diseases.
- Introduction.
- Statistical Analysis.
- Core Success Factors for Companies in this Field.
- Internationalization and Cooperation.
- New Distribution of Roles in the R&D Process.
- Conclusions.
- A. Jungmittag, G. Reger, T. Reiss: Summary and Conclusions.
- Changes in the Innovation Process and Conclusions for R&D-performing Actors.
- Conclusions for Research and Technology Policy..